Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1David A. Barbie, William C. Hahn, Pablo Tamayo et al.|Nature|2009Cited by 4.2k
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell SubpopulationsSreenath V. Sharma, Jeff Settleman, Diana Lee et al.|Cell|2010Cited by 2.8k
Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer MetastasisNicola Aceto, Shyamala Maheswaran, Aditya Bardia et al.|Cell|2014Cited by 2.5k
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal CompositionMin Yu, Shyamala Maheswaran, Aditya Bardia et al.|Science|2013Cited by 2.5k
Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibilityMin Yu, Daniel A. Haber, A. John Iafrate et al.|Science|2014Cited by 911